Mucosal Healing and Clinical Efficacy of Adalimumab in Small Intestinal Crohn’s Disease (SIMCHA Study): Final Results From a Prospective, Open-Label, Single-Arm Study

• Panu Wetwittayakhlang,
• Christine Verdon,
• Michael Starr ,
• Gustavo Drügg Hahn,
• Petra A. Golovics ,
• Talat Bessissow ,
• Waqqas Afif ,
• Gary Wild,
• Alain Bitton,
• Peter L. Lakatos

Affiliations

Panu Wetwittayakhlang

Division of Gastroenterology, McGill University Health Centre, Montreal, Quebec, Canada; Gastroenterology and Hepatology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand

Christine Verdon

Division of Gastroenterology, McGill University Health Centre, Montreal, Quebec, Canada

Michael Starr

Division of Rheumatology, McGill University Health Centre, Montreal, Quebec, Canada

Gustavo Drügg Hahn

Division of Gastroenterology, McGill University Health Centre, Montreal, Quebec, Canada; Universidade Federal do Rio Grande do Sul, School of Medicine, Graduate Course Sciences in Gastroenterology and Hepatology, Porto Alegre, Brazil

Petra A. Golovics

Division of Gastroenterology, McGill University Health Centre, Montreal, Quebec, Canada;Department of Gastroenterology, Hungarian Defence Forces, Medical Centre, Budapest, Hungary

Talat Bessissow

Division of Gastroenterology, McGill University Health Centre, Montreal, Quebec, Canada

Waqqas Afif

Division of Gastroenterology, McGill University Health Centre, Montreal, Quebec, Canada

Gary Wild

Division of Gastroenterology, McGill University Health Centre, Montreal, Quebec, Canada

Alain Bitton

Division of Gastroenterology, McGill University Health Centre, Montreal, Quebec, Canada

Peter L. Lakatos

Division of Gastroenterology, McGill University Health Centre, Montreal, Quebec, Canada; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary